Search results
FDA approves a second Alzheimer's drug that can modestly slow disease - CNBC TV18
CNBC TV18· 2 days agoU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing...
Explained — How Shilpa Medicare benefits from a CDMO customer milestone? - CNBC TV18
CNBC TV18· 14 hours agoThe company informed the exchanges on Thursday regarding a milestone achieved by one of its Contract...
Healthy at Every Size? Here's What Doctors Look for Beyond BMI
Verywell Health· 2 days agoPeople with chronic diseases, in particular, shouldn't place too much importance on BMI, Gitomer...
Human bird flu case found in Colorado, fourth in U.S.
Deseret News· 2 days agoThe worker received antiviral treatment and has recovered. | Rodrigo Abd A new human bird flu case...
Bengaluru civic body BBMP to fine properties over cleanliness amid surge in dengue: Report
Hindustan Times· 7 hours agoAs dengue cases rise, the BBMP mulls imposing fines starting at ₹50 for neglecting premises...
Conduct surprise inspections of govt offices: Yogi | Central India's Premier English Daily
Central Chronicle· 3 hours agoAbhiyan on Friday directed the Basic Shiksha Adhikaris (BSAs) to ensure timely enrolment of children. The CM, who reached Basti on Friday morning, was greeted by public representatives
Eli Lilly Alzheimer's drug approved by US FDA - ET HealthWorld | Pharma
The Economic Times· 2 days agoLondon: The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early...
The state of oligonucleotide therapeutic manufacturing: what biopharmaceutical players need to know
Pharmaceutical Technology· 4 days agoIn the genomic medicine toolbox, oligonucleotide therapeutics offer highly specific and effective ...
New gene editing tool to cure rare disorders | Hyderabad News - Times of India
The Times of India· 3 days agoand Industrial Research - Institute of Genomics and Integrative Biology (CSIR-IGIB) in New Delhi and the LV Prasad Eye Institute (LVPEI ...
Johnson & Johnson reports data from Phase III multiple myeloma treatment trial
Clinical Trials Arena· 2 days agoThe randomised study is designed to assess the efficacy and safety of CARVYKTI against...